A new era of hypertension treatment is on the horizon for U.S. | The drug is the first triple-combo pill for the initial ...

The FDA approved a polypill containing telmisartan, amlodipine, and indapamide, known as Widaplik, for the treatment of ...

UK start-up George Medicines has brought its triple therapy for high blood pressure over the finish line, with an FDA ...

Widaplik marks the first and only FDA-approved triple combination medication that can be used as an initial therapy for patients with hypertension who require multiple drugs to reach their blood ...

Mark Mallon, Chief Executive Officer of George Medicines, said: “Data show that most patients with hypertension will require two or more medicines to bring their blood pressure under control.

The U.S. Food and Drug Administration has approved George Medicines' Widaplik (telmisartan, amlodipine, and indapamide) for ...

The combination will be available in several doses and is also approved as a first-line option for patients with hypertension ...

The FDA has approved a polypill as an initial treatment for hypertension in adults for the first time. Here’s what to know: 1. Widaplik — manufactured by George Medicines — is a polypill that contains ...

Blueprint Medicines stock was soaring Monday after French drugmaker Sanofi said it had agreed to buy the biotech company for ...

Mark Mallon, Chief Executive Officer of George Medicines, said: "Data show that most patients with hypertension will require two or more medicines to bring their blood pressure under control. WIDAPLIK ...